Terminology Service < Semantic Lookup Platform

All terms in EFO

Label	Id	Description
susceptibility to Mycobacterium tuberculosis infection measurement	EFO_0008407	[Quantification of an individual's susceptibility to infection with Mycobacterium tuberculosis]
4-acetamidobutanoate-to-X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide ratio	EFO_0021400	[Quantification of the ratio of 4-acetamidobutanoate to X-03056--N-[3-(2-Oxopyrrolidin-1-yl)propyl]acetamide in a sample.]
10-undecenoate 11:1n1-to-X-11438 ratio	EFO_0021402	[Quantification of the ratio of 10-undecenoate 11:1n1 to X-11438 in a sample.]
ADpSGEGDFXAEGGGVR-to-X-14304--leucylalanine ratio	EFO_0021401	[Quantification of the ratio of ADpSGEGDFXAEGGGVR to X-14304--leucylalanine in a sample.]
saccharin	CHEBI_32111	[A 1,2-benzisothiazole having a keto-group at the 3-position and two oxo substituents at the 1-position. It is used as an artificial sweetening agent.]
benzothiadiazole	CHEBI_48864	[A benzodiazepine (sometimes colloquially "benzo"; often abbreviated "BZD") is a psychoactive drug whose core chemical structure is the fusion of a benzene ring and a diazepine ring. The first benzodiazepine, chlordiazepoxide (Librium), was discovered accidentally by Leo Sternbach in 1955, and made available in 1960 by Hoffmann La Roche, which has also marketed diazepam (Valium) since 1963.[1]]
obsolete_severe motor and intellectual disabilities-sensorineural deafness-dystonia syndrome	Orphanet_369939
Micromelic dwarfism, Fryns type	Orphanet_2641
pursuit maintenance gain measurement	EFO_0008433	[Quantification of the accuracy of matching eye velocity to target velocity during sustained pursuit, typically measured using a video-based eye tracker. Abnormalities of this system have been observed in psychiatric disoreders such as aschizophrenia.]
psychomotor performance	EFO_0004362	[The coordination of a sensory or ideational (cognitive) process and a motor activity.]
initial pursuit acceleration	EFO_0008434	[Quantification of the rate of change of eye velocity during the first 100ms of pursuit, typically measured using a video-based eye-tracker. Abnormalities of this sysmtem have been observed in psychiatric disorders such as schizophrenia.]
gestational weight gain measurement	EFO_0008435	[Quantification of the amount of weight gained by a woman during pregnancy.]
obsolete_SSR4-CDG	Orphanet_370927
late gestational weight gain	EFO_0008436	[Quantification of the amount of weight gained by a woman during late pregnancy.]
IgG monosialylation measurement	EFO_0008430	[Quantification of monosialylated N-glycans of IgG in a biological sample, typically serum]
maximal voluntary ventilation	EFO_0008431	[Qunatification of the maximum volume of air that an organism can breathe in and out during a specified period of time, often 1 minute.]
lipoprotein-associated phospholipase A(2) change measurement	EFO_0008432	[Quantification of the rate of change in lipoprotein-associated phospholipase A(2) over the course of time, used as an indicator of risk of cardiovascular events, and a target for certain cardiovascular drugs.]
Short stature - intellectual disability - eye anomalies - cleft lip/palate	Orphanet_2649
obsolete_STT3A-CDG	Orphanet_370921
obsolete_parastremmatic dwarfism	Orphanet_2646